Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00846248 · ClinicalTrials.gov registry record · NA

Chromium and Insulin Resistance

A NA study of Insulin Resistance, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT00846248 is a NA study of Insulin Resistance that has completed, run by University of California, San Francisco. The registered enrollment target is 75 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00846248, a NA study of Insulin Resistance, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

Chromium is an essential nutrient for the maintenance of normal glucose tolerance and its deficiency causes insulin resistance. Chromium administration has also been shown in several studies to lower glucose and insulin levels in patients with type 2 diabetes. Accordingly, we propose to perform a placebo-controlled study of chromium picolinate administration in a cohort of non-obese, non-diabetic, insulin resistant subjects. These subjects will be randomized to 16 weeks of therapy with either 500 mcg twice a day of Chromium or placebo.

Conditions Studied

Insulin Resistance

Interventions

  • DIETARY_SUPPLEMENT placebo
  • DIETARY_SUPPLEMENT Chromium

Study Locations (1)

California

  • UCSF - San Francisco

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2006-01
Est. Completion 2011-07
Phase NA

Sponsor

University of California, San Francisco

1,713 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00846248

The ClinicalTrials.gov registry entry for NCT00846248 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (69% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Insulin Resistance appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.

NCT00846248 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00846248 about?

NCT00846248 is a clinical study titled "Chromium and Insulin Resistance". Chromium is an essential nutrient for the maintenance of normal glucose tolerance and its deficiency causes insulin resistance. Chromium administration has also been shown in several studies to lower glucose and insulin levels in patients with type 2 diabetes. Accordingly, we propose to perform a pl...

What is the current status of trial NCT00846248?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2006-01. Estimated completion is 2011-07.

What conditions does trial NCT00846248 study?

This clinical trial studies the following conditions: Insulin Resistance.

What interventions are being tested in trial NCT00846248?

The interventions under investigation include: placebo (DIETARY_SUPPLEMENT), Chromium (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00846248?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00846248 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Insulin Resistance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Insulin Resistance

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.